Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Nutrien Ltd.
Bear Case (25th pct.)
-0.5% vs price
Base Case (Median)
12.1% vs price
Bull Case (75th pct.)
33.4% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $78.57 | 12.1% | High (40%) |
| PE Comparable | $82.69 | 18.0% | Medium (25%) |
| Growth Trajectory DCF | $149.75 | 113.7% | Medium (20%) |
| Graham Number | $74.41 | 6.2% | Medium (30%) |
| EV/EBITDA | $104.30 | 48.9% | Medium (20%) |
| EV/FCF | $65.02 | -7.2% | Medium (20%) |
| Earnings Power Value | $25.62 | -63.4% | Medium (50%) |
Based on 7 out of 7 methods, NTR appears fairly valued at the current price of $70.06. The base case fair value of $78.57 implies 12.1% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.